Searle posts Rs1.20bn profit for first quarter of FY27
The pharmaceutical company's consolidated profit climbed 30.77% from a year earlier, while its shares closed at 77.40 rupees on 21 October 2026.
The Searle Company Ltd (ticker SEARL) recorded consolidated profit of Rs1.20bn in the three months to September 2026, up 30.77% from Rs914.15m a year earlier, a rise of about 31%.
On our data, the shares ended at 77.40 rupees on 21 October 2026, gaining 0.98% that day. The stock was down 6.35% over the past month and 14.40% over the past three months. Its closing price has ranged between 75.99 and 135.07 rupees over the past 52 weeks.
The benchmark KSE-100 index closed at 164,867.30 on the same date, 0.17% lower on the day. Searle is a listed pharmaceutical company, and its shares trade on the Pakistan Stock Exchange alongside the wider market tracked by that index.
Profit is what remains of a company's income after costs and expenses are deducted. The quarterly figure is a consolidated one, covering the company together with its subsidiaries.
SEARL and the Pakistan market
Based on reports by Mettis Global. This brief was written by StocksXray in our own words, with prices from our own data. See how our news is made in the editorial standards.
Educational only, not financial advice. Numbers beside the story are from our own data.